About Us

We are an international, interdisciplinary educational and policy-oriented think tank dedicated to advancing the responsible and inclusive application of Artificial Intelligence (AI) and digital health tools in healthcare and biomedical research.
Our Services
Contact Us

The Digital Health Literacy & Policy Hub was founded on the principle that the intersection of digital health, AI, and governance requires dynamic, forward-thinking leadership and proactive engagement with emerging challenges. In an era where innovation reshapes healthcare and policy landscapes daily, we embrace the need for continual adaptation and collaborative problem-solving.

The Hub was co-founded by Dimitri V. Nanopoulos and Olga Tzortzatou-Nanopoulou. Professor Nanopoulos, a distinguished Emeritus Professor with decades of expertise in pioneering research across particle physics, cosmology, and quantum brain studies, brings a deep understanding of complex scientific and technological systems. Dr. Tzortzatou-Nanopoulou, with a strong foundation in law, policy, and technology transfer, has recently transitioned into leading a digital health startup focused on bridging the gap between policy, literacy, and healthcare. Together, they combine their complementary knowledge to tackle the pressing challenges at the intersection of technology, policy, and health equity.

The Hub serves as a think tank, collaborative platform, and knowledge-sharing network, promoting innovative solutions and actionable insights for organizations, policymakers, and researchers. Together, we aim to empower stakeholders to harness the opportunities of digital health and AI responsibly while addressing critical ethical and societal concerns.

By unifying expertise, dialogue, and diverse perspectives, the Digital Health Literacy & Policy Hub aspires to be at the forefront of shaping equitable and sustainable digital health futures.

  • Meet

Founders

Olga Tzortzatou-Nanopoulou

About

Dr. Olga Tzortzatou-Nanopoulou
CEO & Founder / Digital Health / Policy & Literacy Advocate

With nearly 20 years of experience as an in-house lawyer, academic researcher, and as the former Head of the Technology Transfer Office, Dr. Olga Tzortzatou-Nanopoulou transitioned into leading a digital health startup focused on bridging policy, literacy, and healthcare.

As a Principal Investigator in EU-funded projects, Dr. Tzortzatou-Nanopoulou has made significant contributions to advancing biomedical research. She has served as both a Member and Head of Ethics Committees, addressing complex issues surrounding new technologies and biomedical research.

Since 2015, she has also worked as an external ethics expert for the European Research Council (ERC) and the European Commission DG Research & Innovation.

 

Dimitri V. Nanopoulos

About

Dimitri V. Nanopoulos is a Greek-American Distinguished Emeritus Professor with over 30 years of experience as a research fellow at CERN, one of the world’s leading research organizations in particle physics. He is widely recognized as one of the most frequently cited researchers globally, with significant contributions to the fields of particle physics, cosmology, and quantum theory.

His expertise lies in string unified theories, quantum aspects of brain function, and astroparticle physics. Dimitri has authored over 762 original papers and 14 books, accumulating over 56,000 citations, including 19 highly influential papers in his domains. His current research focuses on model building and the phenomenology of F-Theory Supersymmetric Grand Unified Theories (GUTs) at the Large Hadron Collider (LHC), and he is developing new theories in quantum mechanics to better understand brain functions.

As a leader in theoretical physics, he is currently working on blueprints and testing methodologies at the LHC to explore the concept of a No-Scale Multiverse, pushing the boundaries of scientific understanding.

Public Benefit Purposes

Advisory Board

The Advisory Board of the Digital Health Literacy & Policy Hub is composed of distinguished experts in privacy, AI, ethics, digital health, and policy-making. Their guidance ensures that our initiatives are grounded in rigorous research, ethical principles, and real-world relevance. Together, they provide strategic direction, foster impactful collaborations, and support our mission to advance equitable and sustainable digital health solutions worldwide.

Christina Delighianni
About
Ms. Christina Deligianni, an EU Climate Pact Ambassador, is the Policy & Programs Director of the Institute for Sustainable Development at EPLO and the Managing Director of Verimpact, that includes innovative ESG AI-based assessment and training tools. She has more than 20 years of professional experience in public policy, sustainability and business development in the public and private sectors. A linguist by training, she taught English and Translation as an adjunct professor (University of Chicago, University of Athens, French Institute of Athens), and served as Chief of Staff for the Dean of the Hellenic Parliament, and as Senior Advisor at two Greek Ministries. Her high-profile public and political affairs positions (US, and Australian embassies) have added to her experience with different administration and governance systems. Since 2014, she has worked on international and European projects in new technologies, the blue economy, ESG and sustainability for private clients and entities that include the National Fund of Greece, the European Commission, FAO/GFCM, Ominvest and the OMRAN Group. Currently, running three EU-funded research projects on blue economy, deep tech and climate change adaptation. She holds an MA in the Humanities (University of Chicago, Fulbright Scholar), and a BA in English and Greek. She is fluent in Greek, Spanish, English and has studied Mandarin Chinese and Italian.

Prof. Manjit Dosanjh

About

Professor Manjit Dosanjh is the former senior advisor for medical applications at CERN and now a Visiting Professor at the University of Oxford and the Project Leader for STELLA (Smart Technologies to Extend Lives with Linear Accelerators. She holds a Ph.D. in Biochemical Engineering from UK and her professional efforts in medical applications span more than 30 years, during which she has held positions in various academic and research institutions in Europe and the U.S., including the Massachusetts Institute of Technology (MIT), the Lawrence Berkeley National Laboratory (LBNL) at the University of California, the European Commission Joint Research Centre in Italy. She joined CERN in 2000 and focused on applying the technologies developed for particle physics to the life sciences domain and establishing multidisciplinary collaborative approaches for cancer treatment. Her work has included many initiatives to expand access to technology in Low Middle-Income Countries and she is the Project Leader for STELLA (Smart Technologies to Extend Lives with Linear Accelerators) for ICEC (www.iceccancer.org). Manjit is also the Coordinator of ENLIGHT (European Network for Light Ion Hadron Therapy).

In addition, for over 20 years she has worked for civil society initiatives concentrated on raising awareness in disparities in access to STEM and highlighting the importance of STEM for empowerment and development. She is actively involved in helping non-profit health and science education and gender related organizations in the Geneva area and served as the UN representative in Geneva for an NGO in consultative status with ECOSOC for the Graduate Women International-International Federation of University Women for nearly 15 years. Currently she is on the board of directors for ICEC (International Cancer Experts Corps) based in Washington DC with ECOSOC status and a member of the CoNGO (Conference of NGOs) Board.
She is long term member of the NGO Committee on Status of Women Geneva for which she was the editor of the NGO-CSW Geneva Bejing+20 Platform outcome report. She has spoken often on the intersections of health, human rights, diversity and equality and role of STEM for bridging the gap.

Dr. Antoine Harfouche
About
Antoine Harfouche is a ‘MUR (Ministry of University and Research) Brain Gain’ Professor in Tuscia University and is the Rector’s Delegate for Talent Valorization and Attraction. Prof. Harfouche teaches courses on bioethics in Tuscia University, and on creativity, innovation, and bioentrepreneurship in Tuscia University and the Sapienza University of Rome. His science work is described in numerous peer-reviewed scientific articles in prestigious journals. He has extensive experience in R&D growth and leadership in both academia and industry in Europe and the USA. He is the Co-Chair of the ‘Responsible Artificial Intelligence for Sustainable Societies’ ICTO2023 Conference, Sorbonne University, July 2023. He serves on the Scientific Committee of the ‘International Conference on Digitalization and Artificial Intelligence in Agricultural Management’, Stockholm University, November 2023. Prof. Harfouche is an independent ethics expert at the European Research Council and an external expert at the Marie-Skłodowska-Curie Actions, both at the European Commission.
Dr. Andreas Mershin
About

Dr. Andreas Mershin is an MIT Research Scientist and the Director of the MIT Label Free Research Group. He also teaches at the MIT Sloan School Executive Education and Advanced Management programs, has founded and serves as President of the non-profit Osmocosm Foundation, co-founder and director of MycoHab.com and co-founder of artificial dog intelligence olfactory diagnostic startup Scentient. His work spans a wide range from the (quantum) biophysics of the cytoskeleton, learning and memory, photosynthesis and olfaction to perceptual engineering and mycotecture and the physics of odorants.

Dr. Michaela Th. Mayrhofer

About

Michaela Th. Mayrhofer is a political scientist, sociologist and historian by training. Educated in Vienna, Louvain-la-Neuve, Essex and Paris, her academic career led to various positions and stays at the Centre de Recherche Médecine, Sciences, Santé et Société, the University of Vienna, the Institute of Technology and Society Studies at the Alpen-Adria-Universität Klagenfurt/Vienna/Graz, the Technical University of Vienna, the Fondation Brocher and the Medical University of Graz. She retained a Research Fellowship at the Institut für Technik-und Wissenschaftsforschung at the Alpen-Adria-Universität Klagenfurt as well as at the University of Newcastle. In 2010, she gained her PhD from both the University of Vienna and the Ecole des Hautes Edudes en Sciences Sociales (Vienna/Paris) and was shortlisted for best PhD 2010 by the Austrian Political Science Association (ÖGPW). She was a member of the editorial staff of the Austrian Journal of Political Furthermore, she has served as a member, respectively chair on several scientific and ethical advisory boards, ethics advisory boards and review boards. Science (2013-2017) and is a review editor for Frontiers in Genetics (since 2023). Between 2013 and 2025, she worked at BBMRI-ERIC, the research infrastructure for biobanks and bimolecular resources, where she served as Co-Interim Director General (Feb-Aug 2020) and Head of ELSI Services & Research department (2019-2025). Most recently, she joined the Medical University of Innsbruck's Institute of Human Genetics. Her research focus includes the governance of the life sciences.

Danai Spentzou

About

Danai Spentzou holds an LLB from National Kapodistrian University Law School, and an LLM in Human Rights Law from Queen Mary University of London. During the last 3 years she has been working as a policy advisor for legislative files in the field of health and environment, for one of top-20 influential Members of the European Parliament for 2024 according to EUmatrix, and she is currently continuing her work alongside the Vice Chair of the Committee on Environment, Health and Food Safety. In parallel to her work in the parliament, she is a PhD candidate for her research related to the legal and ethical issues of bioengineering, at the School of Applied Mathematical and Physical Sciences in the National Technical University of Athens. She is also a coordinator of the Young Voices in Health Policy, an independent and informal network dedicated to bringing together young professionals in the field of EU health policy.

Dr. Ciara Staunton

About
Dr Ciara Staunton is an independent consultant who specialises on the governance of biobanks, genomics, and the use of health data in research, clinical trials, clinical care, and public health. She was recently a consultant to the WHO on WHO guiding principles for human genome data sharing, has held consultancies for public health organisations such as the Global Fund, the South African National Institute for Communicable Diseases (NICD), the Foundation for Innovative New Diagnostics (FIND), and the Access to COVID-19 Tools Accelerator. She is current the co-lead for the ELSI workpackage for Genome of Ireland. 
globe ai
  • What We Stand For

Digital Health Literacy Policy Hub

  • Equity & Access: Ensuring fair access to digital health technologies for all communities.
  • Ethical Innovation: Addressing ethical issues such as privacy, bias, and transparency in AI tools.
  • Global Collaboration: Uniting experts from academia, industry, and government to shape the future of healthcare technology.
Join Us
Join Us
Scroll to Top